These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9761771)

  • 41. Cross-talk between the proto-oncogenes Met and Ron.
    Follenzi A; Bakovic S; Gual P; Stella MC; Longati P; Comoglio PM
    Oncogene; 2000 Jun; 19(27):3041-9. PubMed ID: 10871856
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatocyte growth factor/scatter factor and its receptor, the c-met proto-oncogene product.
    Rubin JS; Bottaro DP; Aaronson SA
    Biochim Biophys Acta; 1993 Dec; 1155(3):357-71. PubMed ID: 8268192
    [No Abstract]   [Full Text] [Related]  

  • 43. Hepatocyte growth factor-scatter factor (HGF-SF) and the c-met receptor. Introduction.
    Goldberg ID; Rosen EM
    EXS; 1993; 65():xiii-xv. PubMed ID: 8380733
    [No Abstract]   [Full Text] [Related]  

  • 44. Targeting the hepatocyte growth factor/Met pathway in cancer.
    De Silva DM; Roy A; Kato T; Cecchi F; Lee YH; Matsumoto K; Bottaro DP
    Biochem Soc Trans; 2017 Aug; 45(4):855-870. PubMed ID: 28673936
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The cell dissociation and motility triggered by scatter factor/hepatocyte growth factor are mediated through the cytoplasmic domain of the c-Met receptor.
    Komada M; Kitamura N
    Oncogene; 1993 Sep; 8(9):2381-90. PubMed ID: 7689722
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cross-talk between RON receptor tyrosine kinase and other transmembrane receptors.
    Danilkovitch-Miagkova A; Leonard EJ
    Histol Histopathol; 2001 Apr; 16(2):623-31. PubMed ID: 11332718
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hepatocyte growth factor/scatter factor overexpression induces growth, abnormal development, and tumor formation in transgenic mouse livers.
    Sakata H; Takayama H; Sharp R; Rubin JS; Merlino G; LaRochelle WJ
    Cell Growth Differ; 1996 Nov; 7(11):1513-23. PubMed ID: 8930401
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatocyte growth factor/scatter factor (HGF/SF), the c-met receptor and the behaviour of epithelial cells.
    Gherardi E; Sharpe M; Lane K; Sirulnik A; Stoker M
    Symp Soc Exp Biol; 1993; 47():163-81. PubMed ID: 8165564
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas.
    Di Renzo MF; Olivero M; Ferro S; Prat M; Bongarzone I; Pilotti S; Belfiore A; Costantino A; Vigneri R; Pierotti MA
    Oncogene; 1992 Dec; 7(12):2549-53. PubMed ID: 1334253
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A novel recombinant soluble splice variant of Met is a potent antagonist of the hepatocyte growth factor/scatter factor-Met pathway.
    Tiran Z; Oren A; Hermesh C; Rotman G; Levine Z; Amitai H; Handelsman T; Beiman M; Chen A; Landesman-Milo D; Dassa L; Peres Y; Koifman C; Glezer S; Vidal-Finkelstein R; Bahat K; Pergam T; Israel C; Horev J; Tsarfaty I; Ayalon-Soffer M
    Clin Cancer Res; 2008 Jul; 14(14):4612-21. PubMed ID: 18628476
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of scatter factor and the c-met proto-oncogene in angiogenic responses.
    Polverini PJ; Nickoloff BJ
    EXS; 1995; 74():51-67. PubMed ID: 8527901
    [No Abstract]   [Full Text] [Related]  

  • 52. The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-met-urokinase plasminogen activator-plasmin proteolytic network.
    Webb CP; Hose CD; Koochekpour S; Jeffers M; Oskarsson M; Sausville E; Monks A; Vande Woude GF
    Cancer Res; 2000 Jan; 60(2):342-9. PubMed ID: 10667586
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of junction assembly in cultured epithelial cells by hepatocyte growth factor/scatter factor is concomitant with increased stability and altered phosphorylation of the soluble junctional molecules.
    Pasdar M; Li Z; Marreli M; Nguyen BT; Park M; Wong K
    Cell Growth Differ; 1997 Apr; 8(4):451-62. PubMed ID: 9101091
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatocyte growth factor/scatter factor: a heparan sulphate-binding pleiotropic growth factor.
    Lyon M; Gallagher JT
    Biochem Soc Trans; 1994 May; 22(2):365-70. PubMed ID: 7958326
    [No Abstract]   [Full Text] [Related]  

  • 55. Oncogenes related to growth factor receptors.
    Toyoshima K
    Acta Neurochir Suppl (Wien); 1987; 41():110-7. PubMed ID: 2833073
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modulation of intercellular junctions of epithelia by scatter factor (hepatocyte growth factor).
    Nusrat A; Madara JL
    EXS; 1995; 74():69-87. PubMed ID: 8527902
    [No Abstract]   [Full Text] [Related]  

  • 57. Invasive growth: from development to metastasis.
    Comoglio PM; Trusolino L
    J Clin Invest; 2002 Apr; 109(7):857-62. PubMed ID: 11927611
    [No Abstract]   [Full Text] [Related]  

  • 58. Hepatocyte growth factor/scatter factor and the placenta.
    Uehara Y; Kitamura N
    Placenta; 1996; 17(2-3):97-101. PubMed ID: 8730879
    [No Abstract]   [Full Text] [Related]  

  • 59. Cross-talk between CD44 and c-Met in B cells.
    Taher TE; van der Voort R; Smit L; Keehnen RM; Schilder-Tol EJ; Spaargaren M; Pals ST
    Curr Top Microbiol Immunol; 1999; 246():31-7; discussion 38. PubMed ID: 10396036
    [No Abstract]   [Full Text] [Related]  

  • 60. Growth factors and cancer.
    Aaronson SA
    Science; 1991 Nov; 254(5035):1146-53. PubMed ID: 1659742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.